Toward understanding toxicity over time (ToxT) in myeloma cooperative group trials: Feasibility of a novel longitudinal adverse event analysis in ECOG-ACRIN E1A06.

6580Background: Given the many chronically administered agents now used in cancer therapy, there is pressing need to elucidate safety and tolerability of therapy over time. Conventional methods of ...